Whitehawk Therapeutics, Inc.
WHWK· Nasdaq
Released Mar 11, 2021, before the open
10-K filed Mar 11, 2021, 70 days after period end · 0001564590-21-012252
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019 | Q4 2018 | Q4 2017 |
|---|---|---|---|---|
| Revenue | — | — | $2.14K | — |
| Net Income | $8.02M | -$4.45M | -$8.52M | -$6.24M |
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR
| EPS Diluted | — | -$0.11 | -$0.21 | -$0.23 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.